WIVB-TV12h
Tonawanda’s Pine Pharmaceuticals lays off quarter of workforce
Pine Pharmaceuticals of Tonawanda confirmed Thursday that it will lay off 58 employees, or about 25% of its workforce, due to ...
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
HC Wainwright has initiated coverage on Alumis Inc. (NASDAQ:ALMS), a clinical-stage biopharmaceutical company developing oral ...
The Pharma Letter14h
Takeda terminates deal with Wave
RNA specialist Wave Life Sciences has been told by Takeda that the Japanese drugmaker is to bring to an end the last facet of ...
Petri Dish: Takeda splits from Wave; Lilly backs Alzheimer’s biotech
This week’s news from the life sciences includes Eli Lilly's investment in a Cambridge-Singapore biotech, Stealth ...